Cerus Future Growth
Future criteria checks 1/6
Cerus is forecast to grow earnings and revenue by 47.5% and 10.7% per annum respectively while EPS is expected to grow by 48.9% per annum.
Key information
47.5%
Earnings growth rate
48.9%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 10.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 31 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 225 | -4 | N/A | N/A | 4 |
| 12/31/2025 | 206 | -14 | N/A | N/A | 5 |
| 12/31/2024 | 186 | -21 | N/A | N/A | 5 |
| 9/30/2024 | 176 | -20 | -11 | -9 | N/A |
| 6/30/2024 | 170 | -24 | -27 | -23 | N/A |
| 3/31/2024 | 164 | -32 | -37 | -33 | N/A |
| 12/31/2023 | 156 | -37 | -48 | -43 | N/A |
| 9/30/2023 | 154 | -50 | -36 | -30 | N/A |
| 6/30/2023 | 153 | -51 | -25 | -21 | N/A |
| 3/31/2023 | 156 | -46 | -16 | -13 | N/A |
| 12/31/2022 | 162 | -43 | -28 | -26 | N/A |
| 9/30/2022 | 158 | -38 | -26 | -25 | N/A |
| 6/30/2022 | 154 | -42 | -30 | -30 | N/A |
| 3/31/2022 | 145 | -49 | -39 | -38 | N/A |
| 12/31/2021 | 131 | -54 | -35 | -34 | N/A |
| 9/30/2021 | 119 | -60 | -43 | -42 | N/A |
| 6/30/2021 | 107 | -61 | -41 | -40 | N/A |
| 3/31/2021 | 97 | -61 | -41 | -39 | N/A |
| 12/31/2020 | 92 | -60 | -43 | -42 | N/A |
| 9/30/2020 | 85 | -62 | -43 | -41 | N/A |
| 6/30/2020 | 79 | -66 | -62 | -58 | N/A |
| 3/31/2020 | 76 | -69 | -70 | -63 | N/A |
| 12/31/2019 | 75 | -71 | -74 | -65 | N/A |
| 9/30/2019 | 70 | -71 | -73 | -64 | N/A |
| 6/30/2019 | 68 | -67 | -55 | -47 | N/A |
| 3/31/2019 | 65 | -62 | -48 | -43 | N/A |
| 12/31/2018 | 61 | -58 | -32 | -31 | N/A |
| 9/30/2018 | 61 | -53 | -35 | -34 | N/A |
| 6/30/2018 | 56 | -52 | N/A | -42 | N/A |
| 3/31/2018 | 50 | -56 | N/A | -46 | N/A |
| 12/31/2017 | 44 | -61 | N/A | -52 | N/A |
| 9/30/2017 | 37 | -63 | N/A | -52 | N/A |
| 6/30/2017 | 37 | -64 | N/A | -55 | N/A |
| 3/31/2017 | 37 | -65 | N/A | -57 | N/A |
| 12/31/2016 | 37 | -63 | N/A | -54 | N/A |
| 9/30/2016 | 37 | -64 | N/A | -53 | N/A |
| 6/30/2016 | 35 | -65 | N/A | -48 | N/A |
| 3/31/2016 | 34 | -63 | N/A | -48 | N/A |
| 12/31/2015 | 34 | -56 | N/A | -51 | N/A |
| 9/30/2015 | 34 | -61 | N/A | -51 | N/A |
| 6/30/2015 | 36 | -56 | N/A | -51 | N/A |
| 3/31/2015 | 36 | -48 | N/A | -46 | N/A |
| 12/31/2014 | 36 | -39 | N/A | -40 | N/A |
| 9/30/2014 | 36 | -24 | N/A | -38 | N/A |
| 6/30/2014 | 36 | -34 | N/A | -32 | N/A |
| 3/31/2014 | 38 | -33 | N/A | -28 | N/A |
| 12/31/2013 | 40 | -43 | N/A | -27 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CU2 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CU2 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CU2 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CU2's revenue (10.7% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: CU2's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CU2's Return on Equity is forecast to be high in 3 years time